Skip to main content
Livermore
Livermore
ZHEN

Assetmark, Inc

SEC CIK
0001344551
Latest filing
Jul 30, 2026

GSK holding history

GSK plc in every 13F filed by Assetmark, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overviewAll 13F holders of GSKFull Q2 2026 holdings

Shares (Q2 2026)
551,436
Value
$28.9M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of GSK by Assetmark, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026551,436$28.9M<0.1%+70,800+14.7%AddedHolders
Q1 2026480,636$26.5M0.1%+47,772+11.0%AddedHolders
Q4 2025432,864$21.2M<0.1%+69,404+19.1%AddedHolders
Q3 2025363,460$15.7M<0.1%+86,081+31.0%AddedHolders
Q2 2025277,379$10.7M<0.1%+175,476+172.2%AddedHolders
Q1 2025101,903$3.95M<0.1%+26,754+35.6%AddedHolders
Q4 202475,149$2.54M<0.1%+55,354+279.6%AddedHolders
Q3 202419,795$809.2K<0.1%+11,448+137.2%AddedHolders
Q2 20248,347$321.4K<0.1%+4,315+107.0%AddedHolders
Q1 20244,032$172.8K<0.1%+1,450+56.2%AddedHolders
Q4 20232,582$95.7K<0.1%+2,430+1,598.7%AddedHolders
Q3 2023152$5.51K<0.1%−5,867−97.5%ReducedHolders
Q2 20236,019$214.5K<0.1%−1,252−17.2%ReducedHolders
Q1 20237,271$258.7K<0.1%+5,030+224.5%AddedHolders
Q4 20222,241$78.7K<0.1%−8,297−78.7%ReducedHolders
Q3 202210,538$310.0K<0.1%+888+9.2%AddedHolders
Q2 20229,650$420.0K<0.1%+2,892+42.8%AddedHolders
Q1 20226,758$294.0K<0.1%+2,464+57.4%AddedHolders
Q4 20214,294$189.0K<0.1%+660+18.2%AddedHolders
Q3 20213,634$139.0K<0.1%−4,610−55.9%ReducedHolders
Q2 20218,244$328.0K<0.1%−36,710−81.7%ReducedHolders
Q1 202144,954$1.60M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.